Experiments demonstrating that dramatic overexpression of c-Cbl in vivo did not affect EGFR phosphorylation, ubiquitylation and tumor growth (Figure 8), equivalent to cells exposed to low EGF concentrations in vitro, further support the prediction of low concentrations of EGFR ligands and a small pool of active EGFRs in tumors. The gene discussed is EGFR; the disease is neoplasm.